Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) EPS (Weighted Average and Diluted) (2022 - 2023)

Historic EPS (Weighted Average and Diluted) for Molecular Partners Ag (MOLN) over the last 2 years, with Q3 2023 value amounting to -$1968.4.

  • Molecular Partners Ag's EPS (Weighted Average and Diluted) rose 3863.64% to -$1968.4 in Q3 2023 from the same period last year, while for Sep 2023 it was -$1968.4, marking a year-over-year increase of 3863.64%. This contributed to the annual value of -$1.81 for FY2024, which is 1517.55% up from last year.
  • As of Q3 2023, Molecular Partners Ag's EPS (Weighted Average and Diluted) stood at -$1968.4, which was up 3863.64% from -$2.3 million recorded in Q2 2023.
  • In the past 5 years, Molecular Partners Ag's EPS (Weighted Average and Diluted) registered a high of $33.0 billion during Q1 2022, and its lowest value of -$2.6 billion during Q1 2023.